Hamburg, Germany, Tuesday 02 November 2021 10.00 CEST
In a collaboration with Deloitte, GAIA released an extensive publication on the evolution and future of Digital Therapeutics.
The last several years has been pivotal in the world of digital healthcare, with the evolution and adoption of digital therapeutics playing a large role. In this publication, GAIA’s VP of Commercialisation shares his insights on how evidence-based digital therapeutics has the potential to change this landscape even more.
“A lot of people have doubts that software can have such an impact, but it is astonishing to see the results of digital therapeutic interventions in randomised controlled clinical trials”.
Read more here.